Catalyst Pharmaceuticals Inc
CPRX
Market Cap$2.74B
Close$
$16.80
23.9% downside
Current Fair Value
23.9% downsideOvervalued by 23.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.74 Billion |
|---|---|
| Enterprise Value | $2.18 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.38 |
| Beta | 0.72 |
| Outstanding Shares | 121,472,468 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.84 |
|---|---|
| PEG | 9.62 |
| Price to Sales | 5.52 |
| Price to Book Ratio | 3.68 |
| Enterprise Value to Revenue | 4.09 |
| Enterprise Value to EBIT | 9.41 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany